These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 3263144)
1. Interleukin 3 enhances the cytotoxic activity of 1-beta-D-arabinofuranosylcytosine (ara-C) on acute myeloblastic leukaemia (AML) cells. Lista P; Porcu P; Avanzi GC; Pegoraro L Br J Haematol; 1988 Sep; 70(1):121-3. PubMed ID: 3263144 [TBL] [Abstract][Full Text] [Related]
2. Different sensitivity of normal and leukaemic progenitor cells to Ara-C and IL-3 combined treatment. Lista P; Brizzi MF; Rossi M; Resegotti L; Clark SC; Pegoraro L Br J Haematol; 1990 Sep; 76(1):21-6. PubMed ID: 2223644 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of the cytotoxicity of cytosine arabinoside by interleukin-3. Tanaka M Jpn J Cancer Res; 1992 Feb; 83(2):194-9. PubMed ID: 1556000 [TBL] [Abstract][Full Text] [Related]
4. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation. te Boekhorst PA; Löwenberg B; Vlastuin M; Sonneveld P Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839 [TBL] [Abstract][Full Text] [Related]
5. Granulocyte-macrophage colony-stimulating factor and interleukin-3 protect leukemic blast cells from ara-C toxicity. Koistinen P; Wang C; Curtis JE; McCulloch EA Leukemia; 1991 Sep; 5(9):789-95. PubMed ID: 1719308 [TBL] [Abstract][Full Text] [Related]
7. Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells. te Boekhorst PA; Löwenberg B; Sonneveld P Leukemia; 1994 Sep; 8(9):1480-6. PubMed ID: 7522289 [TBL] [Abstract][Full Text] [Related]
8. OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside. Koistinen P; Wang C; Yang GS; Wang YF; Williams DE; Lyman SD; Minden MD; McCulloch EA Leukemia; 1991 Aug; 5(8):704-11. PubMed ID: 1715961 [TBL] [Abstract][Full Text] [Related]
9. Enhanced chemosensitivity in acute myeloid leukemia by hematopoietic growth factors: a comparison of the MTT assay with a clonogenic assay. te Boekhorst PA; Löwenberg B; Sonneveld P Leukemia; 1993 Oct; 7(10):1637-44. PubMed ID: 7692194 [TBL] [Abstract][Full Text] [Related]
10. Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs. Tafuri A; Lemoli RM; Chen R; Gulati SC; Clarkson BD; Andreeff M Leukemia; 1994 May; 8(5):749-57. PubMed ID: 7514244 [TBL] [Abstract][Full Text] [Related]
11. The effect of haemopoietic growth factors on the cell cycle of AML progenitors and their sensitivity to cytosine arabinoside in vitro. Smith MA; Singer CR; Pallister CJ; Smith JG Br J Haematol; 1995 Aug; 90(4):767-73. PubMed ID: 7545422 [TBL] [Abstract][Full Text] [Related]
12. Cytosine arabinoside (ara-C) and cis-dichlorodiammineplatinum II (cisplatin) alone and in combination: effects on acute myeloblastic leukemia blast cells in culture and in vivo. Wang YF; Curtis JE; Lipton J; Minkin S; McCulloch EA Leukemia; 1991 Jun; 5(6):522-7. PubMed ID: 1711641 [TBL] [Abstract][Full Text] [Related]
13. Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia. Hiddemann W; Kiehl M; Zühlsdorf M; Busemann C; Schleyer E; Wörmann B; Büchner T Semin Oncol; 1992 Apr; 19(2 Suppl 4):31-7. PubMed ID: 1553573 [TBL] [Abstract][Full Text] [Related]
14. Haemopoietic growth factors, the cell cycle of acute myeloblastic leukaemia progenitors and sensitivity to cytosine arabinoside. Smith MA; Smith JG; Pallister CJ; Singer CR Leuk Lymphoma; 1996 Nov; 23(5-6):467-72. PubMed ID: 9031077 [TBL] [Abstract][Full Text] [Related]
15. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor. Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834 [TBL] [Abstract][Full Text] [Related]
16. [Activity of various hematopoietic growth factors on acute myeloblastic leukemia blasts]. Almeida J; del Cañizo MC; Vidriales B; Hernández MD; Galende J; San Miguel J Sangre (Barc); 1996 Feb; 41(1):3-8. PubMed ID: 8779032 [TBL] [Abstract][Full Text] [Related]
17. Regulation by retinoic acid and hydrocortisone of the anthracycline sensitivity of blast cells of acute myeloblastic leukemia. Yang GS; Minden MD; McCulloch EA Leukemia; 1994 Dec; 8(12):2065-75. PubMed ID: 7807996 [TBL] [Abstract][Full Text] [Related]
18. Schedule-dependent interaction of cytarabine plus doxorubicin or cytarabine plus mitoxantrone in acute myelocytic leukemia cells in culture. Fountzilas G; Inoue S; Ohnuma T Leukemia; 1990 May; 4(5):321-4. PubMed ID: 2388478 [TBL] [Abstract][Full Text] [Related]
19. Fluorescence-labeling of nicks in DNA from leukemic blast cells as a measure of damage following cytosine arabinoside. Application to the study of regulated drug sensitivity. Yang GS; Wang C; Minden MD; McCulloch EA Leukemia; 1994 Dec; 8(12):2052-9. PubMed ID: 7807994 [TBL] [Abstract][Full Text] [Related]
20. Hydrocortisone in culture protects the blast cells in acute myeloblastic leukemia from the lethal effects of cytosine arabinoside. Yang GS; Wang C; Minkin S; Minden MD; McCulloch EA J Cell Physiol; 1991 Jul; 148(1):60-7. PubMed ID: 1860896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]